580 related articles for article (PubMed ID: 8855941)
1. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
3. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
Doolittle RF; Pandi L
Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
5. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
6. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
Schönbeck U; Mach F; Libby P
J Immunol; 1998 Oct; 161(7):3340-6. PubMed ID: 9759850
[TBL] [Abstract][Full Text] [Related]
7. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Webster L; Chignell AH; Limb GA
Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
9. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
12. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
Hiller O; Lichte A; Oberpichler A; Kocourek A; Tschesche H
J Biol Chem; 2000 Oct; 275(42):33008-13. PubMed ID: 10930399
[TBL] [Abstract][Full Text] [Related]
14. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
15. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
[TBL] [Abstract][Full Text] [Related]
16. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
17. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
Heinz A; Jung MC; Duca L; Sippl W; Taddese S; Ihling C; Rusciani A; Jahreis G; Weiss AS; Neubert RH; Schmelzer CE
FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
[TBL] [Abstract][Full Text] [Related]
18. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
19. [Matrix metalloproteinases and their biological functions].
Solov'eva NI
Bioorg Khim; 1998 Apr; 24(4):245-55. PubMed ID: 9612566
[TBL] [Abstract][Full Text] [Related]
20. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]